Vertex Pharmaceuticals Operating Income 2010-2024 | VRTX

Vertex Pharmaceuticals operating income for the twelve months ending September 30, 2024 was $-0.270B, a 106.97% decline year-over-year.

  • Vertex Pharmaceuticals annual operating income for 2023 was $3.832B, a 11.04% decline from 2022.
  • Vertex Pharmaceuticals annual operating income for 2022 was $4.307B, a 54.83% increase from 2021.
  • Vertex Pharmaceuticals annual operating income for 2021 was $2.782B, a 2.6% decline from 2020.

Vertex Pharmaceuticals Operating Income 2010-2024 | VRTX

  • Vertex Pharmaceuticals annual operating income for 2023 was $3.832B, a 11.04% decline from 2022.
  • Vertex Pharmaceuticals annual operating income for 2022 was $4.307B, a 54.83% increase from 2021.
  • Vertex Pharmaceuticals annual operating income for 2021 was $2.782B, a 2.6% decline from 2020.